CVS adds 4 new board members in deal with Glenview

CVS Health bulks its board up to 16 members, adds hedge fund Glenview’s CEO
CVS Health has added four new board members, including the chief executive of a hedge fund that has been critical of the struggling healthcare giant. The company said Monday that it expanded its board to 16 members following “productive discussions” with shareholder Glenview Capital Management.
CVS Health names four new board members in deal with activist investor
CVS Health said on Monday it named four new members to its board of directors as part of a deal with activist investor Glenview Capital as the healthcare company continues to fight its way out of its brutal 2024.
CVS adds four new board members in deal with Glenview as CEO pursues a turnaround
CVS Health added Glenview Capital's top boss and three others to its board in a deal with the hedge fund, a month after the healthcare conglomerate tasked a new CEO with its turnaround efforts.
CVS Health Adds Four Board Seats In Deal With Hedge Fund
CVS Health said four new members will be added to its board from the hedge fund Glenview Capital, which had been pushing for changes at the diversified healthcare giant.
CVS Adds to Board in Deal With Glenview
Among the new CVS directors is Larry Robbins, chief executive of the hedge fund, which recently took a stake in the healthcare giant.
CVS adds Glenview Capital Management founder to board
CVS has withdrawn its guidance for this year and offered investors no outlook for the next amid struggles in both the pharmacy and insurance businesses.
CVS Health bulks its board up to 16 members, adds hedge fund CEO
CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling health care giant. The company said Monday that it expanded its board to 16 members following “productive discussions” with shareholder Glenview Capital Management.
CVS adds four new board members in deal with Glenview Capital
CVS Health said on Monday it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund's chief executive Larry Robbins. Longtime investor Glenview Capital Management bought 2.
CVS jumps on report it will add to board in deal with hedge fund Glenview
Shares of CVS Health (NYSE:CVS) rose 2.8% in premarket trading on Monday following a report from the Wall Street Journal that the company will expand its board as part of an agreement with Glenview Capital Management,
CVS Health adds four new board members in Glenview Capital deal
CVS Health adds four new board members after engagement with activist investor Glenview Capital Management, boosting shareholder value.
CVS Health Stock Is Moving Higher Monday: What's Going On?
CVS Health Corporation (NYSE: CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here's what you need to know.
New CEO at CVS begins to build his team with a goal of reviving the struggling health care giant
CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...
The Associated Press - Business News on MSN12d
CVS Health Q3 profit misses estimates, company names new leaders at 2 divisions
CVS Health on Wednesday posted a miss in third-quarter profit and named executives for two key divisions CVS Health fell short on third-quarter profit, but it posted strong sales and the ...
Business Insider1d
CVS Health: Strategic Board Enhancements and Undervaluation Drive Buy Rating
Moreover, Anderson’s analysis indicates that CVS is currently undervalued, especially when dissecting the company’s earnings by segment. The Health Care Benefits segment, in particular, seems to ...